BHIC BioScience Health Innovations, Inc.

CIK 0001784440 10 ready 8-Ks latest April 2, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 10

Latest filing April 2, 2026, 7:59 PM ET

Top materiality 0.85

Event mix other_material ×5 · m_and_a ×3 · leadership ×2

Sentiment 0 pos · 1 neg · 9 neu

Executive change recent →

SHENANIGAN SCORE 2 / 7 see the board

Recent 8-K filings for BHIC

Highest-materiality recent filing

Nowtransit Inc. change of control: Justin Earl acquires 51.3% stake, becomes President and sole director

September 1, 2021, 7:59 PM ET other material materiality 0.85 neutral item 5.01 item 5.02 ◈ executive_change ×2

Justin Earl purchased 2,800,000 shares (51.3% of common stock) from former majority shareholder Ivan Homici for $28,000 on April 2, 2021.
Ivan Homici resigned as director, President, Treasurer, and Secretary on July 29, 2021; Justin Earl replaced him in all roles.

Read filing →

April 2, 2026, 7:59 PM ET leadership materiality 0.30 neutral item 5.02

Bioscience Health Innovations board member Justin Earl resigns; Daniel Schmidt appointed director

Justin Earl resigned from the board effective April 1, 2026, with no disagreement on company matters.
October 16, 2025, 7:59 PM ET other material materiality 0.50 neutral item 5.03 item 5.07 item 9.01 ◈ Governance Changes

BioScience Health Innovations enacts 4-for-1 reverse stock split effective Sept. 10, 2025

Reverse stock split ratio of 4 old shares to 1 new share, approved by board and majority stockholder written consent.
March 17, 2025, 7:59 PM ET other material materiality 0.30 neutral item 5.03

Nowtransit changes name to BioScience Health Innovations, Inc. effective Feb 21, 2025

Company name changed from Nowtransit, Inc. to BioScience Health Innovations, Inc. effective February 21, 2025.
June 25, 2024, 7:59 PM ET M&A materiality 0.80 neutral item 1.01 item 2.01 item 5.03 item 9.01 item 4.01 item 3.02 item 5.02 item 5.06 ◈ executive_change ×4◈ M&A Transactions

Nowtransit completes reverse merger with Best Labs; issues 34M shares (85.4%) for supplement business

Issued 34,371,100 shares (85.39% of post-closing shares) to Best Labs shareholders for all of Best's shares; deal closed March 10, 2023.
May 22, 2024, 7:59 PM ET other material materiality 0.50 negative item 4.01 item 9.01

Nowtransit dismisses Spiegel, appoints Mac as auditor after FY2022 going concern

Spiegel dismissed as auditor effective March 10, 2023; Mac appointed March 15, 2023.
March 23, 2023, 7:59 PM ET leadership materiality 0.65 neutral item 5.02 ◈ executive_change

Nowtransit appoints John Chymboryk as CFO effective March 21, 2023

John Chymboryk appointed Chief Financial Officer, effective immediately on March 21, 2023.
March 16, 2023, 7:59 PM ET M&A materiality 0.80 neutral item 2.01 item 3.02 item 5.02 item 5.03 item 5.06 item 1.01 ◈ executive_change ×4◈ Governance Changes ×2◈ M&A Transactions

Nowtransit completes reverse merger with Best Labs; new CEO and board appointed

Nowtransit issued 34,371,100 shares (85.39% of outstanding) for 100% of Best Labs common stock.
February 17, 2023, 6:59 PM ET M&A materiality 0.80 neutral item 1.01 item 9.01 ◈ Material Agreements

Nowtransit to issue 85.39% stake for Best Labs acquisition in share exchange

Nowtransit acquires Best Labs via share exchange; Best shareholders receive 34.37M shares (85.39% post-exchange) for 100% of Best.
November 29, 2022, 6:59 PM ET other material materiality 0.30 neutral item 1.01 item 9.01 ◈ Material Agreements

Nowtransit sells 40,000 Series A convertible preferred shares for $40,000 gross proceeds

Sold 40,000 Series A convertible preferred shares at $1.00/share to an accredited investor, raising $40,000 gross before expenses.
September 1, 2021, 7:59 PM ET other material materiality 0.85 neutral item 5.01 item 5.02 ◈ executive_change ×2

Nowtransit Inc. change of control: Justin Earl acquires 51.3% stake, becomes President and sole director

Justin Earl purchased 2,800,000 shares (51.3% of common stock) from former majority shareholder Ivan Homici for $28,000 on April 2, 2021.